Source: MarketScreener

Destiny: Destiny Pharma : Notice of 2024 Annual General Meeting

(marketscreener.com) THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt about its contents or the action you should take in response to this document, you should seek your own personal financial advice from your stockbroker, bank manager, solicitor, accountant or other independent financial...https://www.marketscreener.com/quote/stock/DESTINY-PHARMA-PLC-37788317/news/Destiny-Pharma-Notice-of-2024-Annual-General-Meeting-46679948/?utm_medium=RSS&utm_content=20240509

Read full article »
Annual Revenue
$5.0-25M
Employees
1-25
Chris Tovey's photo - CEO of Destiny

CEO

Chris Tovey

CEO Approval Rating

82/100

Read more